Suppr超能文献

2018 年更新版:欧洲抗风湿病联盟手骨关节炎管理推荐意见。

2018 update of the EULAR recommendations for the management of hand osteoarthritis.

机构信息

Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Ann Rheum Dis. 2019 Jan;78(1):16-24. doi: 10.1136/annrheumdis-2018-213826. Epub 2018 Aug 28.

Abstract

Since publication of the European League Against Rheumatism (EULAR) recommendations for management of hand osteoarthritis (OA) in 2007 new evidence has emerged. The aim was to update these recommendations. EULAR standardised operating procedures were followed. A systematic literature review was performed, collecting the evidence regarding all non-pharmacological, pharmacological and surgical treatment options for hand OA published to date. Based on the evidence and expert opinion from an international task force of 19 physicians, healthcare professionals and patients from 10 European countries formulated overarching principles and recommendations. Level of evidence, grade of recommendation and level of agreement were allocated to each statement. Five overarching principles and 10 recommendations were agreed on. The overarching principles cover treatment goals, information provision, individualisation of treatment, shared decision-making and the need to consider multidisciplinary and multimodal (non-pharmacological, pharmacological, surgical) treatment approaches. Recommendations 1-3 cover different non-pharmacological treatment options (education, assistive devices, exercises and orthoses). Recommendations 4-8 describe the role of different pharmacological treatments, including topical treatments (preferred over systemic treatments, topical non-steroidal anti-inflammatory drugs (NSAIDs) being first-line choice), oral analgesics (particularly NSAIDs to be considered for symptom relief for a limited duration), chondroitin sulfate (for symptom relief), intra-articular glucocorticoids (generally not recommended, consider for painful interphalangeal OA) and conventional/biological disease-modifying antirheumatic drugs (discouraged). Considerations for surgery are described in recommendation 9. The last recommendation relates to follow-up. The presented EULAR recommendations provide up-to-date guidance on the management of hand OA, based on expert opinion and research evidence.

摘要

自 2007 年欧洲抗风湿病联盟(EULAR)发布手部骨关节炎(OA)管理建议以来,新的证据不断涌现。本研究旨在更新这些建议。EULAR 遵循标准操作程序。对所有已发表的手部 OA 的非药物、药物和手术治疗选择进行了系统的文献回顾。基于证据和来自 10 个欧洲国家的 19 名医生、医疗保健专业人员和患者的国际工作组的专家意见,制定了总体原则和建议。为每个声明分配了证据水平、推荐等级和一致性水平。达成了五项总体原则和十项建议。这些总体原则涵盖了治疗目标、信息提供、治疗个体化、共同决策以及考虑多学科和多模式(非药物、药物、手术)治疗方法的必要性。建议 1-3 涵盖了不同的非药物治疗选择(教育、辅助器具、运动和矫形器)。建议 4-8 描述了不同药物治疗的作用,包括局部治疗(首选局部治疗,而非全身性治疗,局部非甾体抗炎药(NSAIDs)是首选)、口服镇痛药(特别是 NSAIDs,用于缓解有限时间的症状)、硫酸软骨素(缓解症状)、关节内糖皮质激素(一般不推荐,考虑用于指间关节疼痛性 OA)和常规/生物疾病修饰抗风湿药物(不推荐)。建议 9 中考虑了手术治疗。最后一条建议涉及随访。提出的 EULAR 建议基于专家意见和研究证据,为手部 OA 的管理提供了最新的指导。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验